IP Library › Granted Patent US 11,111,466
Granted Patent B2
US 11,111,466 · App. 16/925,713 · Granted Sep 7, 2021

Deactivation wipe kit

Inventors: Mark J. Compo (Doylestown, PA); Michael Balestri (Mechanicsville, VA)
Assignee: Veltek Associates, Inc.
C11D17/049A61L2/18B65B5/045B65B7/02B65B51/10B65B55/08B65D31/14B65D31/145B65D75/5805B65D81/22A61L2/08A61L2202/17B65B55/027B65B2210/06
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,111,466
App. No.
16/925,713
Granted
Sep 7, 2021
Kind
B2
Abstract

A hazardous drug deactivation wipe kit includes a first pouch having a one-way valve coupled to an end thereof, a second pouch, and a third pouch. The first pouch contains a wipe saturated in a hypochlorite solution, the second pouch contains a wipe saturated in thiosulfate solution, and the third pouch contains a wipe saturated in isopropyl alcohol solution. The deactivation wipe kit may be used in a clean room to deactivate most hazardous drugs on a work surface.

Claims (13)

1. A hazardous drug deactivation wipe kit, comprising:

a first pouch having a one-way filling valve coupled to an end thereof, the first pouch containing a first wipe saturated in hypochlorite solution, wherein the first pouch is filled with hypochlorite solution following irradiation sterilization; and

a second pouch containing a second wipe saturated in a solution of thiosulfate, potassium permanganate, or alkaline potassium permanganate.

2. The hazardous drug deactivation wipe kit of claim 1 , further comprising a third pouch containing a third wipe saturated in a solution of isopropyl alcohol, phenol, quaternary ammonium compound, peroxyacetic acid, or hydrogen peroxide.

3. The hazardous drug deactivation wipe kit of claim 1 , wherein the saturated solutions in the first, second, and third wipes are formulated with Water for Injection.

4. The hazardous drug deactivation wipe kit of claim 1 , wherein the saturated solutions in the first, second, and third wipes are filtered.

5. The hazardous drug deactivation wipe kit of claim 1 , wherein the first, second, and third pouches are formed into a multi-layered structure.

6. The hazardous drug deactivation wipe kit of claim 1 , wherein the first, second, and third wipes have non-shedding properties.

7. The hazardous drug deactivation wipe kit of claim 1 , wherein the first, second, and third pouches are hermetically sealed.

8. The hazardous drug deactivation wipe kit of claim 1 , wherein the hermetic seal is a heat seal.

9. The hazardous drug deactivation wipe kit of claim 1 , the first, second, and third pouches are hermetically sealed in a first plastic bag and a second plastic bag.

10. The hazardous drug deactivation wipe kit of claim 1 , wherein the second wipe is comprised of a material that minimizes degradation of the saturated solution.

11. The hazardous drug deactivation wipe kit of claim 1 , wherein the first and second pouches are chemically resistant.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 9, 2020
From: COMPO, MARK J.; BALESTRI, MICHAEL
To: VELTEK ASSOCIATES, INC.
Reel/Frame 053718/0001 →
Continuity (4)
Continuation 16175530 · Oct 30, 2018
Continuation 15271957 · Sep 21, 2016
Provisional Application 62320999 · Apr 11, 2016
Related Publication 20200339921A1 · Oct 29, 2020
Cited By (3)
US 12,296,055 US 12,318,493 US 12,492,061